For plant-based eaters, fortified cereals, nutritional yeast, and B12 supplements can help fill the gap
A phase I trial involving 40 patients with relapsed/refractory HL that the combination of Vorinostat (300 mg/day orally) with sirolimus (4 mg/day orally, n=22) or Everolimus (5-10 mg/day dose escalation, n=18) yielded ORR of 55% and 33%, respectively, with a median progression-free survival (PFS) of 5.8 months, suggesting synergistic efficacy of HDACi combined with mTOR inhibitors (90)
How should I store it
BPC-157 has shown promising results in preclinical research for treating various conditions, including muscle and tendon injuries, gastrointestinal disorders, and inflammation
Avoid intense physical activity, alcohol consumption, and exposure to hot temperatures for at least 24 hours post-injection.